These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32512072)

  • 1. Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats.
    Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E
    Toxicol Appl Pharmacol; 2020 Aug; 401():115101. PubMed ID: 32512072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
    El-Derany MO; El-Demerdash E
    Biochem Pharmacol; 2020 Jul; 177():113942. PubMed ID: 32240652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades.
    Hendawy AS; El-Lakkany NM; Mantawy EM; Hammam OA; Botros SS; El-Demerdash E
    Life Sci; 2022 Sep; 304():120695. PubMed ID: 35671811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats.
    Fawzy MH; Saeed NM; El-Sherbiny DA; El-Demerdash E
    J Pharm Pharmacol; 2021 Apr; 73(6):846-854. PubMed ID: 33822104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M; Csak T; Szabo G
    World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
    Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
    Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis.
    Passos E; Pereira CD; Gonçalves IO; Rocha-Rodrigues S; Silva N; Guimarães JT; Neves D; Ascensão A; Magalhães J; Martins MJ
    Life Sci; 2015 Feb; 123():51-60. PubMed ID: 25534442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis.
    Mohamed RH; Tarek M; Hamam GG; Ezzat SF
    Eur J Pharmacol; 2019 Sep; 858():172469. PubMed ID: 31233751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis.
    Kabel AM; Abd Elmaaboud MA; Albarraq AA
    Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():1-9. PubMed ID: 25541279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats.
    Aboulmagd YM; El-Bahy AAZ; Menze ET; Azab SS; El-Demerdash E
    Eur J Pharmacol; 2020 Aug; 881():173224. PubMed ID: 32454118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model.
    Sabir U; Irfan HM; Alamgeer ; Ullah A; Althobaiti YS; Alshehri FS; Niazi ZR
    Biomed Pharmacother; 2022 Jun; 150():112956. PubMed ID: 35447548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats.
    Sánchez-Quevedo J; Ocampo-Rodríguez E; Alvarez-Ayala E; Rodríguez-López A; Duarte-Vázquez MA; Rosado JL; Rodríguez-Fragoso L
    BMC Pharmacol Toxicol; 2022 Sep; 23(1):75. PubMed ID: 36175992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
    Oniciu DC; Hashiguchi T; Shibazaki Y; Bisgaier CL
    PLoS One; 2018; 13(5):e0194568. PubMed ID: 29847555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation.
    Noori M; Jafari B; Hekmatdoost A
    J Sci Food Agric; 2017 Jun; 97(8):2327-2332. PubMed ID: 27717115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).
    Lee JH; Oh JY; Kim SH; Oh IJ; Lee YH; Lee KW; Lee WH; Kim JH
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.